@ Innovatech surcicat, inc.

OCT 2 4 2003

August 26, 2003

Premarket Notification [510(k)] Summary

Submitter: Innovatech Surgical Inc.
1000 Atlantic Avenue, Suite 514
Camden, NJ 08104
Phone: 800-240-3123
Fax: 856-225-1203

Official Correspondent: Michael J. McGowan, Sr.

Trade Name: _Innovatech Illuminating Laser Probe

Common Name: Ophthalmic Laser Probe

Registration Number: 3003988504

Classification: Class ||

Class Name: We were unable to find the device listed in the Disposable classification regulations, 21
CFR Parts 862-892 [807.87 (c)]

Panel: Ophthalmic

Product Code: HOF

Device Description: The Innovatech Illuminating Laser Probe is an ophthalmic laser delivery device. By
its design, it does not generate, intensify or significantly reduce energy. It consists of
a connector that is plugged into an existing laser source, a glass fiber for laser
delivery and acrylic fiber for illumination with PVC jacket, a Delrin handpiece and 304
stainless needle. The specific laser source to which the probe is connected will be
specified in the “Indications for Use.”

Statement of indications for use: For photocoagulation during ophthalmic surgery. To be used with
(specified equipment).

Page 3-1
1000 Atlantic Avenue, Suite 514, Camden, New Jersey 08104
800-240-3123
innovatechsurgical.com

Kos a4 Dj 2
Substantial Equivalence Comparison
Innovatech Peregrine Illuminated | HGM Illuminating Peregrine Straight
Probe Product: PD600.10 & Associates) Product: PD600.00
Product: 420-30 Manufactured by 510(k): K931784 Manufactured by
Peregrine Surgical Ltd Peregrine Surgical Ltd
510(k): K031023 510(k): K024061
transmission for transmission for transmission for photocoagulation
photocoagulation photocoagulation photocoagulation
Glass — Silica Core Glass — Silica Core Glass — Silica Core Glass — Silica Core
.008” (200 microns: .008” (200 microns: .008” (200 microns) -008” (200 microns)
| Length 101 inches | Length 101 inches__| Length 96 inches" [Length 101 inches __|
1 watt 41 watt 1 watt 41 watt
[iiiumination | tilumination | tliumination” | Noiillumination |
Sterility
The Device will be ETO Sterilized.
The method used to validate the sterilization cycle is AAM! Overkill Method.
Page 3-2

\
} ‘ 7
i ¢ DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
%
Pe Food and Drug Administration
9200 Corporate Boulevard
OCT 9 4 2003 Rockville MD 20850
Mr. Michael J. McGowan, Sr.
Innovatech Surgical, Inc.
1000 Atlantic Avenue, Suite 514
Camden, New Jersey 08104
Re: K032704
Trade/Device Name: Innovatech Illuminating Laser Probe
Regulation Number: 21 CFR 878.4810, 886.4390
‘ Regulation Name: Laser surgical instrument for use in general and
plastic surgery and in dermatology, Ophthalmic laser :
Regulatory Class: II /
Product Code: GEX, HQF :
Dated: August 26, 2003
Received: September 2, 2003
Dear Mr. McGowan:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and: prohibitions against misbranding and
/ adulteration. .
If your device is classified (see above) into either class I] (Special Controls) or class IJ] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CIR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation contro! provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{
Page 2 - Mr. Michael J. McGowan, Sr. ,
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market. ,
: If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled.
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
, (301) 443-6597 or at its Internet address http://www. fda.gov/edrh/dsma/dsmamain.hum| .
Sincerely yours, .
€(etia M. Witten, Ph.D., MD.
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and Radiological Health
Enclosure .

a ce
STATEMENT OF INDICATIONS FOR USE
510(k) Number (if known): KO 2 aT a
Device Name: Innovatech Iliuminating Laser Probe
indications for Use: For photocoagulation and illumination during ophthalmic surgery. This
device delivers illumination, as well as laser energy, to target tissue causing
coagulation. Spot size can be varied by altering the distance between the
tissue and the probe tip.
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED:
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use xX OR , Over-The-Counter Use.
(Division Sign-Off)
Division of General, Restorative
and Neurological Devices
510(k) Number_X 032704
Page 3-3

